GENEVA, Dec. 15 -- PANDORA ENDOCRINE INNOVATION B.V. (Kastanjelaan 91861 ES Bergen) filed a patent application (PCT/EP2025/064654) for "MALE ORAL CONTRACEPTIVE" on May 27, 2025. With publication no. WO/2025/252544, the details related to the patent application was published on Dec 11, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): COELINGH BENNINK, Herman Jan Tijmen (Kastanjelaan 91861 ES Bergen)
Abstract: The invention relates to an oral dosage unit for use in a method of contraception in a human male, said oral dosage units containing GnRH antagonist and dehydroepiandrosterone (DHEA), th...